A detailed history of New York State Common Retirement Fund transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 22,491 shares of AXSM stock, worth $2.39 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
22,491
Previous 13,648 64.79%
Holding current value
$2.39 Million
Previous $1.23 Million 55.09%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 31, 2025

BUY
$83.08 - $100.49 $734,676 - $888,633
8,843 Added 64.79%
22,491 $1.9 Million
Q3 2024

Oct 28, 2024

SELL
$78.93 - $95.84 $347,292 - $421,696
-4,400 Reduced 24.38%
13,648 $1.23 Million
Q2 2024

Jul 31, 2024

SELL
$65.72 - $80.5 $425,997 - $521,801
-6,482 Reduced 26.42%
18,048 $1.45 Million
Q1 2024

May 07, 2024

SELL
$69.39 - $97.64 $244,044 - $343,399
-3,517 Reduced 12.54%
24,530 $1.96 Million
Q4 2023

Feb 01, 2024

BUY
$57.42 - $83.61 $175,245 - $255,177
3,052 Added 12.21%
28,047 $2.23 Million
Q3 2023

Nov 07, 2023

BUY
$69.25 - $82.21 $98,681 - $117,149
1,425 Added 6.05%
24,995 $1.75 Million
Q2 2023

Aug 07, 2023

SELL
$58.41 - $90.35 $104,904 - $162,268
-1,796 Reduced 7.08%
23,570 $1.69 Million
Q1 2023

May 02, 2023

SELL
$58.39 - $75.0 $296,212 - $380,475
-5,073 Reduced 16.67%
25,366 $1.57 Million
Q4 2022

Jan 30, 2023

BUY
$39.94 - $79.72 $354,108 - $706,797
8,866 Added 41.1%
30,439 $2.35 Million
Q3 2022

Nov 08, 2022

BUY
$36.06 - $69.85 $2,812 - $5,448
78 Added 0.36%
21,573 $963,000
Q2 2022

Aug 04, 2022

SELL
$21.74 - $46.75 $934 - $2,010
-43 Reduced 0.2%
21,495 $823,000
Q4 2021

Feb 02, 2022

SELL
$30.7 - $43.36 $8.32 Million - $11.8 Million
-271,017 Reduced 92.64%
21,538 $814,000
Q3 2021

Nov 02, 2021

SELL
$19.91 - $68.26 $100,326 - $343,962
-5,039 Reduced 1.69%
292,555 $9.64 Million
Q2 2021

Aug 02, 2021

SELL
$50.63 - $73.5 $305,197 - $443,058
-6,028 Reduced 1.99%
297,594 $20.1 Million
Q1 2021

May 11, 2021

BUY
$55.91 - $81.44 $2.77 Million - $4.04 Million
49,588 Added 19.52%
303,622 $17.2 Million
Q4 2020

Feb 08, 2021

BUY
$66.31 - $86.52 $3.12 Million - $4.07 Million
47,082 Added 22.75%
254,034 $20.7 Million
Q3 2020

Nov 05, 2020

BUY
$68.34 - $85.84 $5.05 Million - $6.35 Million
73,921 Added 55.57%
206,952 $14.7 Million
Q2 2020

Aug 07, 2020

BUY
$49.87 - $98.69 $460,699 - $911,698
9,238 Added 7.46%
133,031 $10.9 Million
Q1 2020

May 06, 2020

BUY
$41.2 - $101.31 $2.26 Million - $5.56 Million
54,845 Added 79.55%
123,793 $7.28 Million
Q4 2019

Feb 05, 2020

BUY
$16.71 - $106.24 $674,215 - $4.29 Million
40,348 Added 141.08%
68,948 $7.13 Million
Q3 2019

Nov 07, 2019

BUY
$20.24 - $29.16 $72,864 - $104,976
3,600 Added 14.4%
28,600 $579,000
Q2 2019

Aug 09, 2019

BUY
$13.46 - $25.75 $336,500 - $643,750
25,000 New
25,000 $644,000

Others Institutions Holding AXSM

About Axsome Therapeutics, Inc.


  • Ticker AXSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,878,000
  • Market Cap $4.56B
  • Description
  • Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...
More about AXSM
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.